UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS
The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor a...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LAWRENCE, R. MICHAEL ROBERGE, JACQUES YVES QIAO, JENNIFER X LAM, PATRICK Y.S THIBEAULT, CARL CHAO, HANNGUANG J RUEL, REJEAN BOUTHILLIER, GILLES TUERDI, HUJI HERPIN, TIMOTHY WANG, TAMMY C SCHNUR, DORA M LIU, YALEI CLARK, CHARLES G GUNGOR, TIMUR L'HEUREUX, ALEXANDRE L REHFUSS, ROBERT P |
description | The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1751113B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1751113B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1751113B13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAsDqL-w_2Aw1nEOY0XE7B3IbkOTqVInEQL9f9RwQ9westbmtxnsmBZ7Uk4Fi0gHtLugpDJUVLJ0Bfy_RkigwYC_XztiPUbNWTpWtHowAkfo0bhsjaL23if6-bnyoAndWFbp-dQ52m81kd9DZTwsEfEpsXmj_IGcUovMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS</title><source>esp@cenet</source><creator>LAWRENCE, R. MICHAEL ; ROBERGE, JACQUES YVES ; QIAO, JENNIFER X ; LAM, PATRICK Y.S ; THIBEAULT, CARL ; CHAO, HANNGUANG J ; RUEL, REJEAN ; BOUTHILLIER, GILLES ; TUERDI, HUJI ; HERPIN, TIMOTHY ; WANG, TAMMY C ; SCHNUR, DORA M ; LIU, YALEI ; CLARK, CHARLES G ; GUNGOR, TIMUR ; L'HEUREUX, ALEXANDRE L ; REHFUSS, ROBERT P</creator><creatorcontrib>LAWRENCE, R. MICHAEL ; ROBERGE, JACQUES YVES ; QIAO, JENNIFER X ; LAM, PATRICK Y.S ; THIBEAULT, CARL ; CHAO, HANNGUANG J ; RUEL, REJEAN ; BOUTHILLIER, GILLES ; TUERDI, HUJI ; HERPIN, TIMOTHY ; WANG, TAMMY C ; SCHNUR, DORA M ; LIU, YALEI ; CLARK, CHARLES G ; GUNGOR, TIMUR ; L'HEUREUX, ALEXANDRE L ; REHFUSS, ROBERT P</creatorcontrib><description>The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.</description><language>eng ; fre ; ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100310&DB=EPODOC&CC=EP&NR=1751113B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100310&DB=EPODOC&CC=EP&NR=1751113B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAWRENCE, R. MICHAEL</creatorcontrib><creatorcontrib>ROBERGE, JACQUES YVES</creatorcontrib><creatorcontrib>QIAO, JENNIFER X</creatorcontrib><creatorcontrib>LAM, PATRICK Y.S</creatorcontrib><creatorcontrib>THIBEAULT, CARL</creatorcontrib><creatorcontrib>CHAO, HANNGUANG J</creatorcontrib><creatorcontrib>RUEL, REJEAN</creatorcontrib><creatorcontrib>BOUTHILLIER, GILLES</creatorcontrib><creatorcontrib>TUERDI, HUJI</creatorcontrib><creatorcontrib>HERPIN, TIMOTHY</creatorcontrib><creatorcontrib>WANG, TAMMY C</creatorcontrib><creatorcontrib>SCHNUR, DORA M</creatorcontrib><creatorcontrib>LIU, YALEI</creatorcontrib><creatorcontrib>CLARK, CHARLES G</creatorcontrib><creatorcontrib>GUNGOR, TIMUR</creatorcontrib><creatorcontrib>L'HEUREUX, ALEXANDRE L</creatorcontrib><creatorcontrib>REHFUSS, ROBERT P</creatorcontrib><title>UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS</title><description>The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAsDqL-w_2Aw1nEOY0XE7B3IbkOTqVInEQL9f9RwQ9westbmtxnsmBZ7Uk4Fi0gHtLugpDJUVLJ0Bfy_RkigwYC_XztiPUbNWTpWtHowAkfo0bhsjaL23if6-bnyoAndWFbp-dQ52m81kd9DZTwsEfEpsXmj_IGcUovMA</recordid><startdate>20100310</startdate><enddate>20100310</enddate><creator>LAWRENCE, R. MICHAEL</creator><creator>ROBERGE, JACQUES YVES</creator><creator>QIAO, JENNIFER X</creator><creator>LAM, PATRICK Y.S</creator><creator>THIBEAULT, CARL</creator><creator>CHAO, HANNGUANG J</creator><creator>RUEL, REJEAN</creator><creator>BOUTHILLIER, GILLES</creator><creator>TUERDI, HUJI</creator><creator>HERPIN, TIMOTHY</creator><creator>WANG, TAMMY C</creator><creator>SCHNUR, DORA M</creator><creator>LIU, YALEI</creator><creator>CLARK, CHARLES G</creator><creator>GUNGOR, TIMUR</creator><creator>L'HEUREUX, ALEXANDRE L</creator><creator>REHFUSS, ROBERT P</creator><scope>EVB</scope></search><sort><creationdate>20100310</creationdate><title>UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS</title><author>LAWRENCE, R. MICHAEL ; ROBERGE, JACQUES YVES ; QIAO, JENNIFER X ; LAM, PATRICK Y.S ; THIBEAULT, CARL ; CHAO, HANNGUANG J ; RUEL, REJEAN ; BOUTHILLIER, GILLES ; TUERDI, HUJI ; HERPIN, TIMOTHY ; WANG, TAMMY C ; SCHNUR, DORA M ; LIU, YALEI ; CLARK, CHARLES G ; GUNGOR, TIMUR ; L'HEUREUX, ALEXANDRE L ; REHFUSS, ROBERT P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1751113B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2010</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LAWRENCE, R. MICHAEL</creatorcontrib><creatorcontrib>ROBERGE, JACQUES YVES</creatorcontrib><creatorcontrib>QIAO, JENNIFER X</creatorcontrib><creatorcontrib>LAM, PATRICK Y.S</creatorcontrib><creatorcontrib>THIBEAULT, CARL</creatorcontrib><creatorcontrib>CHAO, HANNGUANG J</creatorcontrib><creatorcontrib>RUEL, REJEAN</creatorcontrib><creatorcontrib>BOUTHILLIER, GILLES</creatorcontrib><creatorcontrib>TUERDI, HUJI</creatorcontrib><creatorcontrib>HERPIN, TIMOTHY</creatorcontrib><creatorcontrib>WANG, TAMMY C</creatorcontrib><creatorcontrib>SCHNUR, DORA M</creatorcontrib><creatorcontrib>LIU, YALEI</creatorcontrib><creatorcontrib>CLARK, CHARLES G</creatorcontrib><creatorcontrib>GUNGOR, TIMUR</creatorcontrib><creatorcontrib>L'HEUREUX, ALEXANDRE L</creatorcontrib><creatorcontrib>REHFUSS, ROBERT P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAWRENCE, R. MICHAEL</au><au>ROBERGE, JACQUES YVES</au><au>QIAO, JENNIFER X</au><au>LAM, PATRICK Y.S</au><au>THIBEAULT, CARL</au><au>CHAO, HANNGUANG J</au><au>RUEL, REJEAN</au><au>BOUTHILLIER, GILLES</au><au>TUERDI, HUJI</au><au>HERPIN, TIMOTHY</au><au>WANG, TAMMY C</au><au>SCHNUR, DORA M</au><au>LIU, YALEI</au><au>CLARK, CHARLES G</au><au>GUNGOR, TIMUR</au><au>L'HEUREUX, ALEXANDRE L</au><au>REHFUSS, ROBERT P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS</title><date>2010-03-10</date><risdate>2010</risdate><abstract>The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP1751113B1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A16%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAWRENCE,%20R.%20MICHAEL&rft.date=2010-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1751113B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |